Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-01 Sale |
2024-02-02 4:10 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
46,489 | $1.68 | $78,102 | 3,353,939 (Indirect Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 4:10 pm |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
24,311 | $1.68 | $40,842 | 1,014,676 (Direct) |
View |
| 2023-05-25 Sale |
2023-05-25 9:01 pm |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
63,186 | $1.2229 | $77,270 | 724,344 (Direct) |
View |
| 2023-05-25 Sale |
2023-05-25 9:01 pm |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
95,478 | $1.2229 | $116,760 | 774,037 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-18 6:20 pm |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
63,567 | $1.068 | $67,890 | 530,487 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-18 6:19 pm |
Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer |
63,567 | $1.068 | $67,890 | 446,483 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 08:01 am |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
91,868 | $0.8775 | $80,614 | 1,888,728 (Indirect Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 08:01 am |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
13,034 | $0.8775 | $11,437 | 287,530 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 08:01 am |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
14,123 | $0.8775 | $12,393 | 594,054 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 08:01 am |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
20,412 | $0.8775 | $17,912 | 269,515 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 08:00 am |
Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer |
7,210 | $0.8775 | $6,327 | 510,050 (Direct) |
View |
| 2023-02-27 Sale |
2023-03-01 4:07 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
38,632 | $0.8132 | $31,416 | 1,980,596 (Indirect Direct) |
View |
| 2023-02-27 Sale |
2023-03-01 4:06 pm |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
7,539 | $0.8132 | $6,131 | 608,177 (Direct) |
View |
| 2023-02-27 Sale |
2023-03-01 4:06 pm |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
10,090 | $0.8132 | $8,205 | 289,927 (Direct) |
View |
| 2023-02-27 Sale |
2023-03-01 4:05 pm |
Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer |
7,539 | $0.8132 | $6,131 | 517,260 (Direct) |
View |
| 2023-02-27 Sale |
2023-03-01 4:05 pm |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
6,677 | $0.8132 | $5,430 | 300,564 (Direct) |
View |
| 2022-08-31 Sale |
2022-09-01 4:15 pm |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
1,147 | $0.3625 | $416 | 418,016 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-31 Option Award |
2024-02-02 4:11 pm |
N/A 2034-01-31 |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
373,300 | $0 | 950,337 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:10 pm |
N/A 2034-01-31 |
Akebia Therapeutics Inc. | AKBA | Snow Ellen SVP, CFO and Treasurer |
373,300 | $0 | 743,300 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:10 pm |
N/A 2034-01-31 |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
373,300 | $0 | 900,644 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:10 pm |
N/A 2034-01-31 |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
1,508,700 | $0 | 3,353,939 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:10 pm |
N/A 2034-01-31 |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
505,500 | $0 | 1,014,676 (Direct) |
View |
| 2023-07-31 Option Award |
2023-08-01 4:35 pm |
N/A 2033-07-31 |
Akebia Therapeutics Inc. | AKBA | Snow Ellen SVP, CFO and Treasurer |
930,000 | $0 | 930,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:08 pm |
2024-06-06 2033-06-06 |
Akebia Therapeutics Inc. | AKBA | ZUMWALT LEANNE M Director |
75,000 | $0 | 88,700 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:08 pm |
2024-06-06 2033-06-06 |
Akebia Therapeutics Inc. | AKBA | ROGERS MICHAEL W Director |
75,000 | $0 | 141,029 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:07 pm |
2024-06-06 2033-06-06 |
Akebia Therapeutics Inc. | AKBA | FRIESON RON Director |
75,000 | $0 | 88,700 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:07 pm |
2024-06-06 2033-06-06 |
Akebia Therapeutics Inc. | AKBA | Wolf Myles Director |
75,000 | $0 | 112,681 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:07 pm |
2024-06-06 2033-06-06 |
Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director |
75,000 | $0 | 179,800 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:07 pm |
2024-06-06 2033-06-06 |
Akebia Therapeutics Inc. | AKBA | Smith Cynthia Director |
75,000 | $0 | 140,233 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:07 pm |
2024-06-06 2033-06-06 |
Akebia Therapeutics Inc. | AKBA | GILMAN STEVEN C Director |
75,000 | $0 | 132,130 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 9:01 pm |
N/A 2032-05-12 |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
200,000 | $0 | 724,344 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 9:01 pm |
N/A 2032-05-12 |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
200,000 | $0 | 774,037 (Direct) |
View |
| 2023-05-12 Option Award |
2023-05-16 4:10 pm |
N/A N/A |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
100,000 | $0 | 387,530 (Direct) |
View |
| 2023-05-12 Option Award |
2023-05-16 4:09 pm |
N/A N/A |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
200,000 | $0 | 469,515 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 4:15 pm |
N/A 2033-01-31 |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
1,803,438 | $0 | 3,529,541 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 4:14 pm |
N/A 2033-01-31 |
Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer |
490,500 | $0 | 819,099 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 4:14 pm |
N/A 2033-01-31 |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
490,500 | $0 | 910,016 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 08:11 am |
2023-05-12 2032-06-08 |
Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer |
200,000 | $0 | 528,599 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-09 5:01 pm |
2023-06-08 2032-06-08 |
Akebia Therapeutics Inc. | AKBA | ZUMWALT LEANNE M Director |
33,800 | $0 | 33,800 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-09 5:00 pm |
2023-06-08 2032-06-08 |
Akebia Therapeutics Inc. | AKBA | Wolf Myles Director |
33,800 | $0 | 57,781 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-09 4:59 pm |
2023-06-08 2032-06-08 |
Akebia Therapeutics Inc. | AKBA | Smith Cynthia Director |
33,800 | $0 | 85,333 (Direct) |
View |